1. Home
  2. MEIP vs MSGM Comparison

MEIP vs MSGM Comparison

Compare MEIP & MSGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEIP
  • MSGM
  • Stock Information
  • Founded
  • MEIP 2000
  • MSGM 2018
  • Country
  • MEIP United States
  • MSGM United States
  • Employees
  • MEIP N/A
  • MSGM N/A
  • Industry
  • MEIP Biotechnology: Pharmaceutical Preparations
  • MSGM Computer Software: Prepackaged Software
  • Sector
  • MEIP Health Care
  • MSGM Technology
  • Exchange
  • MEIP Nasdaq
  • MSGM Nasdaq
  • Market Cap
  • MEIP 13.3M
  • MSGM 13.8M
  • IPO Year
  • MEIP 2003
  • MSGM 2021
  • Fundamental
  • Price
  • MEIP $2.80
  • MSGM $2.85
  • Analyst Decision
  • MEIP Hold
  • MSGM Hold
  • Analyst Count
  • MEIP 1
  • MSGM 1
  • Target Price
  • MEIP N/A
  • MSGM $5.00
  • AVG Volume (30 Days)
  • MEIP 13.3K
  • MSGM 49.7K
  • Earning Date
  • MEIP 05-13-2025
  • MSGM 08-08-2025
  • Dividend Yield
  • MEIP N/A
  • MSGM N/A
  • EPS Growth
  • MEIP N/A
  • MSGM N/A
  • EPS
  • MEIP N/A
  • MSGM N/A
  • Revenue
  • MEIP N/A
  • MSGM $7,416,879.00
  • Revenue This Year
  • MEIP N/A
  • MSGM $69.07
  • Revenue Next Year
  • MEIP N/A
  • MSGM $30.56
  • P/E Ratio
  • MEIP N/A
  • MSGM N/A
  • Revenue Growth
  • MEIP 33.76
  • MSGM N/A
  • 52 Week Low
  • MEIP $1.46
  • MSGM $0.73
  • 52 Week High
  • MEIP $4.10
  • MSGM $3.50
  • Technical
  • Relative Strength Index (RSI)
  • MEIP 78.43
  • MSGM 52.94
  • Support Level
  • MEIP $2.21
  • MSGM $2.69
  • Resistance Level
  • MEIP $2.95
  • MSGM $2.90
  • Average True Range (ATR)
  • MEIP 0.15
  • MSGM 0.14
  • MACD
  • MEIP 0.05
  • MSGM -0.04
  • Stochastic Oscillator
  • MEIP 81.48
  • MSGM 46.11

About MEIP MEI Pharma Inc.

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

About MSGM Motorsport Games Inc.

Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.

Share on Social Networks: